Litigation attorney Patricia Carreiro offers an analysis of whether malpractice or cyber insurance coverage - or neither - would come into play if a patient was injured as a result of a cyberattack against a healthcare entity, including an assault targeting a medical device.
The National Health Service in England should have been able to block the "unsophisticated" WannaCry ransomware outbreak, U.K. government auditors have found. Security experts say the findings should be studied by senior executives across all industries to "learn from the mistakes of others."
Malware is widely available in an "as-a-service" model on the cybercriminal underground to anyone with criminal intent and a bit of money, says John Shier, senior security adviser at Sophos, who explains exactly how the model works in this in-depth interview.
Medical device cybersecurity scrutiny usually focuses on potential patient safety issues. But vulnerabilities identified in a cardiac pacemaker programming device illustrate the risks also posed to patient data privacy, says Billy Rios, a researcher who discovered the problem.
Trying once again to clarify that security patches to medical devices usually don't need regulatory approval, the Food and Drug Administration has issued final guidance clarifying exactly when manufacturers must have the agency review device modifications.
The BadRabbit ransomware attack appears to have been designed for smokescreen, disruption or extortion purposes, if not all of the above. So who's gunning for Ukraine and how many organizations will be caught in the crossfire?
Much of the world's critical infrastructure gets controlled by ICS or SCADA systems. But passive network traffic analysis by industrial control system security firm CyberX found vulnerable protocols, widespread Windows XP use and other concerns.
As a digital forensics investigator, Vesta Matveeva of Russia's Group-IB has great insight into the latest cyberattack trends - and the attackers. What conclusions can we draw about how to bolster defenses in 2018?
If Eugene Kaspersky had attended Wednesday's House hearing on the risk his company's anti-virus software poses to the U.S. federal government, he would have faced an unfriendly reception. But Kaspersky wasn't invited, although the panel may "entertain" the possibility of inviting him to a future hearing, according to...
As organizations combat BadRabbit, the latest global ransomware campaign, healthcare entities in the U.S. should monitor the situation and take preventive measures to avoid becoming the next potential victim of any emerging malware, experts advise.
Anti-virus vendor Kaspersky Lab says that an internal probe has confirmed that in 2014 a PC running its anti-virus software flagged and submitted new Equation Group APT malware variants. But after an analyst realized the provenance of the source code, the firm says its CEO ordered that it be immediately deleted.
New ransomware called BadRabbit is directly targeting at least 200 organizations, primarily in Russia and Ukraine. The crypto-locking malware demands a ransom, payable in bitcoins, in exchange for a decryption key, and it appears to borrow code from NotPetya ransomware.
In a battle to save its reputation, Kaspersky Lab says it will allow independent inspections of its code, infrastructure and processes following U.S. government accusations that it colluded with Russian intelligence agencies. But will the move restore confidence?